Lower prescription drug prices and increase access to effective and innovative medical treatments.

Thomas H. Kean, Jr. · New Jersey · Republican

policy impact 0.83 specificity 0.86 extraction confidence 94%

Commitment kind: unknown. Promised action: not established. Promised outcome: not established. Deadline: unknown; not assumed expired.

Contest this claim

Occurrences

Additionally, any reform must include plans for lowering drug prices and increasing access to effective and innovative medical treatments.

Kean commits to drug price reduction and broader access to treatments as part of health reform.

Health | Congressman Thomas Kean Jr.
secondary · other · model gpt-5.4-mini

Our bipartisan legislation will fix that problem by ensuring those savings are passed on to patients. This solution will protect access to essential prescription drugs, reduce overall healthcare costs for families, and hold these health companies accountable.

Kean backs legislation to require copay assistance to count toward patient cost-sharing, lowering out-of-pocket prescription drug costs and improving access to needed medications.

Kean, Colleagues Introduce Bill to Protect Patients from High Prescription Drug Costs | Congressman Thomas Kean Jr.
secondary · other · model gpt-5.4-mini

Evidence

legacy_unverified · Source version not recorded · locator unknown

Rep. Kean sponsored H.R.6423, the HELP Copays Act, introduced December 4, 2025. The bill would require certain third-party prescription-drug financial assistance to count toward deductibles, coinsurance, copayments, and out-of-pocket limits. Congress.gov lists the latest action as referral to House Energy and Commerce and Ways and Means and the status as Introduced.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): Concrete action toward lower prescription drug costs exists, but the bill has not advanced beyond introduction/referral, so the commitment remains unresolved rather than delivered.

unresolved same_term A for effort

H.R.6423 - HELP Copays Act, 119th Congress
secondary · model gpt-5.5 · confidence 94%

Contest this evidence item

legacy_unverified · Source version not recorded · locator unknown

H.R.8725 was introduced by Rep. Caraveo with Rep. Kean of New Jersey as an original cosponsor. The bill required HHS reports on Medicare Part D and MA-PD monthly capped cost-sharing elections, including outreach and point-of-sale implementation. Congress.gov lists the latest action as referred to the Subcommittee on Health and the status as Introduced in the 118th Congress.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): Kean took a concrete cosponsorship step related to medication access and managing drug costs for seniors, but the 118th Congress measure did not become law.

never same_term A for effort

H.R.8725 - Increasing Medication Access for Seniors Act of 2024, 118th Congress
secondary · model gpt-5.5 · confidence 90%

Contest this evidence item

Assessments

Public state: unverified As of unknown · legacy_unverified · . Original AI recommendation (not independently established): unresolved. same_term A for effort

Kean has taken concrete federal legislative action toward the promise by sponsoring the 119th Congress HELP Copays Act and previously cosponsoring a medication-access bill in the 118th Congress. However, the cited measures have not been enacted, and the pending 119th Congress bill has not yet delivered lower prescription drug prices or expanded treatment access as an implemented outcome. Because Kean is still serving and the relevant current-term legislation remains pending rather than failed, the promise is unresolved rather than delivered or never fulfilled.

provider codex_cli · model gpt-5.5 · confidence 87%